AlphAIAlphAI — Financial news for AI agents
seekingalpha.comOCT 292 min read$CROX

Crocs beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook

Crocs reported Q3 Non-GAAP EPS of $3.69, exceeding estimates by $0.38. Revenue rose 4.4% year-over-year to $1.04B, surpassing expectations by $40M. The company raised its FY26 revenue growth forecast to 3% from a prior estimate.

Original reporting
seekingalpha.com
Published Oct 29, 2026, 11:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CROX
Bullish
high confidence
Mentioned
$CROX
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

The earnings surprise and raised guidance are likely to drive short‑term buying interest, especially in pre‑market trading.

02

Market read

Earnings beat for a mid‑cap consumer brand offers a clear trading catalyst.

03

What to watch

Supply‑chain constraints or inventory buildup could temper future growth despite the beat.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Crocs released its Q3 2026 earnings, beating both revenue and EPS expectations and provided an updated FY2026 outlook.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Q3 non‑GAAP EPS of $3.69 beats consensus by $0.38 and revenue of $1.04 B exceeds estimates by $40 M.

Expected impact

upward pressure as the market prices in the earnings beat and raised FY2026 guidance.

Evidence & confidence

Both earnings and guidance are fresh primary disclosures; beats are material for a mid‑cap consumer brand.

Market effects

Sector

Positive signal for the apparel and footwear sector, may boost peers.

Regional

U.S. consumer discretionary stocks could see modest gains.

Global

Limited to U.S. markets; no direct global ripple.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short‑term profit‑taking.

Key entities

  • company
    Crocs, Inc.

    Footwear manufacturer reporting Q3 2026 results.

Read at source← All news

StoryCrocs posts Q3 2026 earnings beat and lifts full‑year outlook

Also covered by

5 outlets

Related articles

OCT 30
$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

investing.com1 min
OCT 30
$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

investing.com2 min
OCT 30
$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.

asiae.co.kr2 min